Randhawa Simrat
- SEC CIK
- 0001992260
In the past year, 4 open-market sale filings worth $15.0M and no purchases.
Current role at each company
- DNTH Dianthus Therapeutics, Inc.EVP, Head of R&Das of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $15.0M
- 4 filings
- Net
- −$15.0M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Randhawa Simrat as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)4:30 PM ET | Sep 1 | 2 days | Randhawa SimratEVP, Head of R&D | SSale | −23.1K | $106.41 | −$2.46M | −85.3%4.00K after | 3 lots10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Randhawa SimratEVP, Head of R&D | SSale | −26.5K | $90.62 | −$2.40M | −86.9%4.00K after | 3 lots10b5-1 |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Randhawa SimratEVP, Head of R&D | SSale | −33.8K | $81.48 | −$2.76M | −100.0%0 after | 10b5-1 |
| Nov 14, 2025 (view filing) | Nov 13-14 | 1 day | Randhawa SimratEVP, Head of R&D | SSale | −196.5K | $37.55 | −$7.38M | −98.0%4.00K after | 4 lots10b5-1 |
| Sep 25, 2023 (view filing) | Sep 21-22 | 4 days | Randhawa SimratChief Medical Officer | PPurchase | +4.00K | $13.20 | +$52.8K | New position4.00K after | 2 lots |